BDBM802070 methyl (S)-3-((2S,4R)-1-((S)- 5-acetyl-3,7,7-trimethyl- 5,6,7,8-tetrahydro-4H-[1,2,3] triazolo[1,5-a][1,4]diazepine- 8-carbonyl)-4-hydroxypyrrol- idine-2-carboxamido)-3-(4-(4- methylthiazol-5-yl)phenyl)- propanoate::US20260108613, Compound A15

SMILES COC(=O)C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H]3n2nnc(C)c2CN(C(C)=O)CC3(C)C)c5ccc(c4scnc4C)cc5

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 802070   

Targetvon Hippel-Lindau disease tumor suppressor(Human)
University of Michigan

US Patent
LigandChemical structure of BindingDB Monomer ID 802070BDBM802070(methyl (S)-3-((2S,4R)-1-((S)- 5-acetyl-3,7,7-trime...)
Affinity DataIC50: 5.30nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/2/2026
Entry Details
US Patent